Nephroprotection in Diabetes
About the event
¿Did you know that up to 50% of patients with type 2 diabetes have diabetic kidney disease (DKD)?
DKD is thought to result from oxidative stress due to hyperglycemia and is a marker of overall endothelial dysfunction. Therefore, evidence shows that tight glycemic control aids greatly in the protection of patients’ kidneys. The soundest conclusion that we can produce from these facts is that patients with type 2 diabetes NEED renal-safe and renal-protective treatment
The ADVANCE trial proved that intensive-glucose lowering based on Gliclazide MR offered exactly this. Watch the whole presentation to get the full scoop!
SCAC 09/23 DM 548 SERVIER For the exclusive use of health professionals
Don't miss our next events!
Subscribe to our newsletter to receive invitations to upcoming events
You can unsubscribe at any time by clicking on the link in our emails.